Patients with Parkinson’s disease (PD) have essentially the same life expectancy as people without PD. This means that patients, especially those who are diagnosed early in life, will require treatment for a very long period of time (30 years and more). In this video, Dr. Stern explains 2 more invasive approaches that allow the patient to improve their symptoms while also reducing their medications. In particular, Dr. Stern discusses the use of DBS and DUOPA, which delivers a gel formulation of levodopa directly into the small intestine.
World Parkinson Coalition